Search

Total results: 221.

Effect of Renin-Angiotensin-Aldosterone System Inhibitors in Patients with COVID-19

  • 27 August 2020

Effect of Renin-Angiotensin-Aldosterone System Inhibitors in Patients with COVID-19: a Systematic Review and Meta-analysis of 28,872 Patients Click Here to read more

Read more

African Studies - COVID-19 Focus

  • 03 June 2020

African Studies - COVID-19 Focus WHF Global Study on CVD and COVID-19 To better understand the intersection between cardiovascular disease and COVID-19, the World Heart Federation (WHF) has launched a global prospective cohort study which aims to better describe cardiovascular outcomes and identify cardiovascular risk factors associated with poor prognosis…

Read more

PASCAR and WHF Cardiovascular Disease Scorecard Project: Cameroon Country Report

  • 15 May 2020 | PASCAR and WHF Cardiovascular Disease Scorecard Project: Cameroon Country Report

PASCAR and WHF Cardiovascular Disease Scorecard Project: Cameroon Country Report

Read more

European Journal of Cardiovascular Nursing & ESC - Delivering healthcare during COVID-19

  • 13 May 2020

Although attention is focused on addressing the acute situation created by the COVID-19 illness, it is imperative to continue our efforts to prevent cardiovascular morbidity and mortality, particularly during a period of prolonged social isolation which may limit physical activity, adversely affect mental health and reduce access to usual care.…

Read more

ESC Guidance for the Diagnosis and Management of CV Disease during the COVID-19 Pandemic

  • 24 April 2020

The European Society of Cardiology (ESC) has assembled a group of experts and practitioners with experience in the care of COVID-19 patients to provide a guidance document relevant for all aspects of CV care during the COVID-19 pandemic. Click Here to read more

Read more

AFHRA

  • 17 April 2020

AFHRA

Read more

Special EP on EP Episode: QTc Monitoring With Drug Therapy During COVID-19

  • 15 April 2020

In this HRS EP on EP episode, Eric N. Prystowsky, MD, FHRS, interviews Michael John Ackerman, MD, PhD to discuss QTc monitoring with drug therapy during COVID-19. Click here for the video: https://www.hrsonline.org/COVID19-Challenges-Solutions/special-ep-ep-episode-qtc-monitoring-drug-therapy-during-covid-19

Read more

COVID-19 Disease: Infection Prevention and Control Guidelines

  • 15 April 2020

The World Health Organization (WHO) declared COVID-19 a global pandemic on 11th March 2020. SARS CoV-2 (a novel coronavirus) originated in Wuhan, China where the first cases were reported in late December 2019, and spread rapidly across the globe. The first case was diagnosed in South Africa on 5th March…

Read more

COVID-19 Corona Virus South African Resource Portal​​

  • 15 April 2020

What is COVID-19? On 31 December 2019, the World Health Organization (WHO) reported a cluster of pneumonia cases in Wuhan City, China. ‘Severe Acute Respiratory Syndrome Coronavirus 2’ (SARS-CoV-2) was confirmed as the causative agent of what we now know as ‘Coronavirus Disease 2019’ (COVID-19). Since then, the virus has…

Read more

COVID-19 Disease: Infection Prevention and Control Guidelines

  • 14 April 2020 | COVID-19 Disease: Infection Prevention and Control Guidelines

COVID-19 Disease: Infection Prevention and Control Guidelines Version 1 April 2020

Read more